D-1134-2017 Class III Terminated
FDA drug recall D-1134-2017 was initiated by Ascend Laboratories LLC on May 5, 2017 and is designated Class III. Reason for recall: PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg. The recall status is terminated (terminated Apr 25, 2018). Affected quantity: 1212 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 20, 2017
- Initiation Date
- May 5, 2017
- Termination Date
- Apr 25, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1212 bottles
Product description
AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10
Reason for recall
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.
Distribution pattern
Nationwide in the USA.
Code information
Lot #: 6142626, Exp 09/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1134-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026